Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vericel Corporation
(NQ:
VCEL
)
46.28
+0.14 (+0.30%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vericel Corporation
< Previous
1
2
3
4
5
Next >
Jim Cramer Believes Penn National Is A Winner, Likes Vericel
December 27, 2021
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Penn National Gaming, Inc. (NASD...
Via
Benzinga
Vericel (VCEL) Q3 2021 Earnings Call Transcript
November 09, 2021
VCEL earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 09, 2021
Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the...
Via
Benzinga
Recap: Vericel Q3 Earnings
November 09, 2021
Vericel (NASDAQ:VCEL) reported its Q3 earnings results on Tuesday, November 9, 2021 at 08:00 AM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Earnings Scheduled For November 9, 2021
November 09, 2021
Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter. • KT (NYSE:KT) is projected to report earnings...
Via
Benzinga
Understanding Vericel's Unusual Options Activity
August 03, 2021
Vericel (NASDAQ:VCEL) shares experienced unusual options ...
Via
Benzinga
Recap: Vericel Q1 Earnings
May 05, 2021
Shares of Vericel (NASDAQ:VCEL) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share rose 30.00% year over year to ($0.07), which...
Via
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 29, 2021
Gainers MiNK Therapeutics (NASDAQ:INKT) shares rose 16.88% to $16.96 during Friday's regular session. Vocera Communications (NYSE:VCRA) shares increased by 12.13% to $...
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Exposures
Product Safety
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
Vericel (VCEL) Q2 2021 Earnings Call Transcript
August 04, 2021
VCEL earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Earnings Scheduled For August 4, 2021
August 04, 2021
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to...
Via
Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
58 Biggest Movers From Yesterday
June 30, 2021
Gainers BSQUARE Corporation (NASDAQ: BSQR) shares jumped 206.9% to close at $8.04 on Tuesday on abnormally-high volume possibly amid increased attention from retail investors....
Via
Benzinga
Why Vericel Tumbled by Nearly 15% on Tuesday
June 29, 2021
The FDA says "no" to the company's NexoBrid -- for now.
Via
The Motley Fool
Exposures
Product Safety
Why Shares Of MediWound And Vericel Fell On Tuesday
June 29, 2021
Shares of MediWound (NASDAQ: MDWD) and its development partner, Vericel Corporation (NASDAQ: VCEL), are trading lower after MediWound received a Complete Response Letter from the...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 29, 2021
Gainers Cerevel Therapeutics Hldg (NASDAQ:CERE) stock moved upwards by 93.55% to $24.33 during Tuesday's regular session. As of 12:30 EST, this security is trading at...
Via
Benzinga
FDA Strikes Off MediWound - Vericel's NexoBrid Biologics License Application; Stocks Drop
June 29, 2021
Vericel Corporation's (NASDAQ:VCEL) devel...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout
June 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,...
Via
Benzinga
The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus
June 27, 2021
Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment. Eli Lilly and Company (NYSE: LLY) stood out among big...
Via
Benzinga
Exposures
Product Safety
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
June 01, 2021
The FDA review machinery worked overtime in May, completing reviews of several drug applications. Except for stray rejections or delays, the agency churned out mostly positive...
Via
Benzinga
Exposures
Product Safety
Vericel (VCEL) Q1 2021 Earnings Call Transcript
May 06, 2021
VCEL earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Stocks That Hit 52-Week Highs On Friday
June 25, 2021
This morning 143 companies set new 52-week highs. Noteables: Adobe (NASDAQ:ADBE) was the biggest company by market cap to set a new 52-week high. The smallest...
Via
Benzinga
The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs
June 25, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
Stocks That Hit 52-Week Highs On Thursday
June 24, 2021
Before 10 a.m. ET on Thursday, 145 companies set new 52-week highs. Noteworthy Highlights: The largest company by market cap to hit a new 52-week high was Microsoft...
Via
Benzinga
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
June 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
May 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
April 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.